These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2128736)

  • 1. Construction and characterization of adriamycin-loaded canine red blood cells as a potential slow delivery system.
    Tonetti M; Astroff B; Satterfield W; De Flora A; Benatti U; DeLoach JR
    Biotechnol Appl Biochem; 1990 Dec; 12(6):621-9. PubMed ID: 2128736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties of doxorubicin encapsulated in glutaraldehyde-treated canine erythrocytes.
    Tonetti M; Astroff AB; Satterfield W; De Flora A; Benatti U; DeLoach JR
    Am J Vet Res; 1991 Oct; 52(10):1630-5. PubMed ID: 1767983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes.
    Zocchi E; Tonetti M; Polvani C; Guida L; Benatti U; De Flora A
    Biotechnol Appl Biochem; 1988 Dec; 10(6):555-62. PubMed ID: 3148305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte based delivery system of primaquine: in vitro characterization.
    Talwar N; Jain NK
    J Microencapsul; 1992; 9(3):357-64. PubMed ID: 1403486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation of adriamycin in human erythrocytes.
    De Flora A; Benatti U; Guida L; Zocchi E
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7029-33. PubMed ID: 3462740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and toxicity of doxorubicin encapsulated in glutaraldehyde-treated erythrocytes administered to dogs with lymphosarcoma.
    Matherne CM; Satterfield WC; Gasparini A; Tonetti M; Astroff AB; Schmidt RD; Rowe LD; DeLoach JR
    Am J Vet Res; 1994 Jun; 55(6):847-53. PubMed ID: 7944027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of amikacin-loaded human carrier erythrocytes.
    Gutiérrez Millán C; Bax BE; Castañeda AZ; Marinero ML; Lanao JM
    Transl Res; 2008 Aug; 152(2):59-66. PubMed ID: 18674740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of anthracycline drugs with canine and bovine carrier erythrocytes.
    DeLoach JR; Droleskey R
    J Appl Biochem; 1985; 7(4-5):332-40. PubMed ID: 3867661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumor activity of adriamycin by encapsulation in mouse erythrocytes targeted to liver and lungs.
    Benatti U; Zocchi E; Tonetti M; Guida L; Polvani C; De Flora A
    Pharmacol Res; 1989; 21 Suppl 2():27-33. PubMed ID: 2631085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
    Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
    Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of phosphatidylserine distribution in human red blood cells during the process of loading sugars.
    Quan GB; Liu MX; Ren SP; Zhang JG; Han Y
    Cryobiology; 2006 Aug; 53(1):107-18. PubMed ID: 16762335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cells as carriers for delivering of proteins.
    Zolla L; Lupidi G; Marcheggiani M; Falcioni G; Brunori M
    Ann Ist Super Sanita; 1991; 27(1):97-103. PubMed ID: 1958034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entrapment of protein protease inhibitors in red blood cells.
    Falcioni G; Gabbianelli R; Santroni AM; Concetti A; Zolla L; Brunori M
    Biotechnol Appl Biochem; 1992 Dec; 16(3):269-74. PubMed ID: 1282323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of glucose oxidase-loaded human erythrocytes: a model of oxidative cytotoxicity.
    De Flora A; Guida L; Zocchi E; Tonetti M; Benatti U
    Ital J Biochem; 1986; 35(5):361-7. PubMed ID: 3804702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and targeting characteristics of adriamycin after canine hepatic arterial embolization with adriamycin-lipiodol emulsion].
    Wang XY; Yang L; Cheng YH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1428-30. PubMed ID: 15604078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell loading with hexokinase and hexokinase-inactivating antibodies. A new strategy for studying the role of enzymes in red cell metabolism and removal.
    Magnani M; Rossi L; Bianchi M; Serafini G; Stocchi V
    Biomed Biochim Acta; 1990; 49(2-3):S149-53. PubMed ID: 2386500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaraldehyde-treated carrier erythrocytes for organ targeting of methotrexate in dogs.
    DeLoach JR; Barton C
    Am J Vet Res; 1981 Nov; 42(11):1971-4. PubMed ID: 6802043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro experimental study of adriamycin-loaded chitosan drug delivery system].
    Zhang Y; Hou C; Chen A
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1997 Sep; 11(5):309-11. PubMed ID: 9867937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
    Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
    Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery.
    Hamidi M; Zarei N; Zarrin AH; Mohammadi-Samani S
    Int J Pharm; 2007 Jun; 338(1-2):70-8. PubMed ID: 17317049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.